Don Weissman, MD


Life Sciences and Healthcare


 Marketing and Communications 

Medical and Regulatory Affairs

KOL, HCP, C-Suite Relationships

Initiatives, Alliances, Partnerships 


Biopharmaceuticals, Therapeutics

Diagnostics, Devices

Lifestyle Medicine, Genetics, AI 


Clinical & Commercial Optimization

Patient Benefits, Caretaker, Stakeholder Values


Consultant and Advisor to Life Science Companies and Projects



 

"A MISSION OF BETTER HEALTH and QUALITY OF LIFE

 

LifeSciences and Healthcare

Medical Science Liaison
Medical and Regulatory Affairs

Strategic Business Development

  Marketing, Communications, Transactions   

   

Proven track record helping Life Science Companies, 

 KOLs, Scientists, MDs, Entrepreneurs,

Clinical and Academic Institutions accelerate 

product utilization and commercial optimization,

growing market share and success for patient benefits,

better outcomes and quality of life. 

  

Exceptional relationships, experience and success,

communicating the values, differentials and benefits of 

Life Style Medicine and Therapeutics

 growing and Building Professional Consensus


 

Excellent Key Opinion Leader and HCP relationships

sharing insights, scientific exchange and HEOR

accelerating trials, applications, 

 adoption and advocacy.


Advisory Board Development, Honored Society

  and Management Relationships with LifeScience

  Corporations, University Medical Centers, 

Physicians of Influence, Regional and National

Decision Makers and Advocacy Groups.

 

Analyst, grant review and panel member:

The National Science Foundation, the NSF 

The National Institute of Health, the NIH and 

The Department of Health & Human Services, the HHS



Adept listener, articulate and persuasive, 
building professional consensus for 
applications, approvals, advocacy,
coverage and better outcomes.
 
Highly successful with the FDA, FTC, PhRMA, 
AHRQ and CMS. Proven track record of success for coverage
with government, insurance, payors and plans.
 

Honored society, academic and board relationships for strategic CME,
regional and national symposium, publications, communications,

 brand and market development, mobile and social media
for patient benefits and stakeholder values.

 

Extraordinary resources, knowledge and success

building and strengthening internal and external 

partnerships, alliances and goal realization.



GOALS:

 

                

Better therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


To optimize patient well being and quality of life,

caretaker, provider and stakeholder values.


 Excellence
clinical, operational and economic outcomes.